Dexamfetamine (Noumed) 5 mg tab: Supply issue
Due to delays at the manufacturing plant, the supplier has low stock of the Noumed 5 mg dexamfetamine tablet (Pharmacode: 2647516).
Affected product
The supplier has limited supply of the following product due to delays at the manufacturing plant:
Dexamfetamine sulfate
- Presentation: Tab 5 mg
- Brand: Noumed Dexamfetamine
- Pharmacode: 2647516
- Subsidy: $29.80
- Measure / Qty: per 100
Alternative brand
The supplier has brought a different brand of dexamfetamine to New Zealand to ensure people can continue to access their medicine.
This has the same active ingredient in the same quantity as the Noumed brand. It will work in the body in the same way.
Inactive ingredients are slightly different
The inactive ingredients in the Aspen brand of dexamfetamine contain gluten, which may cause issues for people who are coeliac or have an intolerance to gluten products.
Pharmacies will need to consider prioritising the Noumed brand for people with coeliac disease or gluten intolerance, because it does not contain gluten. Prescribers may need to consider alternatives for people with coeliac disease.
Funded from 1 April 2026
- Brand: Dexamfetamine Aspen
- Presentation: tab 5 mg
- Pharmacode: 2642298
- Subsidy: $29.80
- Measure / Qty: per 100
- General Supply Issue A5 Flier [PDF 111 KB]
Expected resupply June 2026
The supplier expects to have Noumed brand dexamfetamine available again in June 2026.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)